NKGen Biotech, Inc. Common Stock
NKGen Biotech, Inc. Common Stock (NKGN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NKGN · as of Jun 9, 2026
Key Statistics
Explore NKGen Biotech, Inc. Common Stock Data
nkgn stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
nkgn competitorsNKGN
ATXI
BCTXZ
DRMA
ELAB
MLECStock Performance
Full HistoryAbout NKGen Biotech, Inc. Common Stock
NKGen Biotech, Inc. Common Stock NKGen Biotech, Inc., a biotechnology company in the clinical trial phase, was established in 2017 and has its headquarters in Santa Ana, California. This company is dedicated to creating and marketing…
what is nkgen biotech, inc. common stock · nkgn stock overview · nkgen biotech, inc. common stock company profile · who is nkgen biotech, inc. common stock ceo · nkgn OTC · nkgen biotech, inc. common stock headquarters · nkgen biotech, inc. common stock business segments
About Stock Overview & Key Data
NKGen Biotech, Inc. Common Stock (NKGN) is a Healthcare company in the Biotechnology industry, listed on OTC since Oct 2, 2023. As of the latest trading session, NKGN stock price is $0.06, with a market capitalization of $7.8M. The stock has returned -82.35% over the past 12 months and +20.00% year-to-date.
In fiscal year 2024, NKGen Biotech, Inc. Common Stock reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, NKGen Biotech, Inc. Common Stock (NKGN) stock price is $0.06. The stock is traded on OTC under the ticker symbol NKGN. The 52-week range is $0.00 – $0.77.